The Analysis of Remedium Capital Partners, LLC's Holdings & P&L


Currently, Remedium Capital Partners, LLC holds 6 types of securities in its portfolio with a total value $319.8M. In the most recent quarter, they have increased their positions in N/A (+1.9M shares, valued at $49.9M), SYRE (+451.1K shares, valued at $22.8M), ORKA (+336.7K shares, valued at $16.5M).


1M P&L
+33.6M+7.55%
3M P&L
+125.5M+35.60%
HY P&L
+287.3M+150.56%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology260.2M
100.0%

Top Industries by Stock Count

1Biotechnology4 stocks
100.0%
Stock Holdings
SYRE
Spyre Therapeutics Inc
30.98%
Shares1.9M
Event2026-03-31
Filed2026-05-13
ORKA
Oruka Therapeutics Inc
21.69%
Shares1.9M
Event2026-03-31
Filed2026-05-13
Damora Therapeutics Inc
Damora Therapeutics Inc
1597.87%
Shares2.0M
Event2026-03-31
Filed2026-05-13
APGE
Apogee Therapeutics Inc
0.00%
Shares583.6K
Event2026-03-31
Filed2026-05-13
JBIO
Jade Biosciences Inc
0.00%
Shares1.6M
Event2026-03-31
Filed2026-05-13
Crescent Biopharma Inc
Crescent Biopharma Inc
0.00%
Shares361.3K
Event2026-03-31
Filed2026-05-13

Call Option Holdings
No call option holdings data available

Put Option Holdings
No put option holdings data available
Remedium Capital Partners, LLC Institutional Holdings, Portfolio & P&L β€” TradeFomo